• Title of article

    Inhibition of FLT3 and PDGFR tyrosine kinase activity by bis(benzo[b]furan-2-yl)methanones Original Research Article

  • Author/Authors

    Siavosh Mahboobi، نويسنده , , Andrea Uecker، نويسنده , , Christophe Cénac، نويسنده , , Andreas Sellmer، نويسنده , , Emerich Eichhorn، نويسنده , , Sigurd Elz، نويسنده , , Frank-D. B?hmer، نويسنده , , Stefan Dove، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 2007
  • Pages
    11
  • From page
    2187
  • To page
    2197
  • Abstract
    A series of bis(benzo[b]furan-2-yl)methanones was synthesized and tested for inhibition of FLT3 and PDGFR autophosphorylation. Mostly, C-5 substitution leads to PDGFR selectivity, which was strongest in the case of the 5,5′-dimethoxy derivative. The 5,5′-diamino and the 6,6′-dihydroxy compounds are more active at FLT3. At both kinases, the potency of the best inhibitors approaches IC50 values of ca. 0.5 μM. Molecular modeling studies suggest that the bisbenzofuranylmethanones are able to fit into the same binding site as their indolyl analogues which have been suggested to form a bidentate hydrogen bridge with the backbone in the hinge regions. The loss of one H bond by the NH–O exchange might be partially compensated by, for example, the weak interaction of one furanyl oxygen with FLT3 Cys-828.
  • Keywords
    Bisbenzofuranylmethanone , Receptor tyrosine kinase , FLT3 , PDGFR , Bisindolylmethanone , Benzofuranylindolylmethanone
  • Journal title
    Bioorganic and Medicinal Chemistry
  • Serial Year
    2007
  • Journal title
    Bioorganic and Medicinal Chemistry
  • Record number

    1305424